Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Common Stock | Options Exercise | $175K | +5K | +6.68% | $35.01 | 79.8K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $155K | +5K | +6.26% | $30.94 | 84.8K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $94.9K | +5K | +5.89% | $18.98 | 89.8K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $21.8K | +5K | +5.57% | $4.35* | 94.8K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $101K | +6.5K | +6.85% | $15.52 | 101K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $141K | +7.5K | +7.4% | $18.74 | 109K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $59.4K | +5K | +4.59% | $11.87 | 114K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $59.6K | +5K | +4.39% | $11.91 | 119K | Feb 9, 2022 | Direct | |
transaction | FCX | Common Stock | Sale | -$1.91M | -44K | -37.03% | $43.44 | 74.8K | Feb 9, 2022 | Direct | F2, F3 |
holding | FCX | Common Stock | 1.97K | Feb 9, 2022 | By 401(k) | F1 | |||||
holding | FCX | Common Stock | 3.79K | Feb 9, 2022 | By Spouse Through GRAT | ||||||
holding | FCX | Common Stock | 3.79K | Feb 9, 2022 | Through GRAT |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5K | -100% | $0.00* | 0 | Feb 9, 2022 | Common Stock | 5K | $35.01 | Direct | F4 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5K | -100% | $0.00* | 0 | Feb 9, 2022 | Common Stock | 5K | $30.94 | Direct | F4 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5K | -50% | $0.00 | 5K | Feb 9, 2022 | Common Stock | 5K | $18.98 | Direct | F4 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5K | -12.99% | $0.00 | 33.5K | Feb 9, 2022 | Common Stock | 5K | $4.35 | Direct | F4 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -6.5K | -39.39% | $0.00 | 10K | Feb 9, 2022 | Common Stock | 6.5K | $15.52 | Direct | F4 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -7.5K | -30% | $0.00 | 17.5K | Feb 9, 2022 | Common Stock | 7.5K | $18.74 | Direct | F5 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5K | -14.29% | $0.00 | 30K | Feb 9, 2022 | Common Stock | 5K | $11.87 | Direct | F5 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5K | -11.11% | $0.00 | 40K | Feb 9, 2022 | Common Stock | 5K | $11.91 | Direct |
Id | Content |
---|---|
F1 | Based on plan statement as of December 31, 2021. |
F2 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $43.4200 - $43.4850. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
F3 | Amount beneficially owned includes 59,999 RSUs. |
F4 | 25% exercisable on the date indicated and 25% exercisable on each of the next three anniversaries thereof. |
F5 | 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof. |